Stéphane Bancel

“These Phase 3 findings represent a pivotal moment for the field of cancer research,”

Stéphane Bancel · said 2026-08-19 · reported 2026-08-19

Bancel commented on the Phase 3 trial results announced in the companies' news release.

“For many years, the idea of creating an mRNA treatment designed specifically for an individual patient’s cancer was aspirational. We are now helping turn that vision into a reality.”

Stéphane Bancel · said 2026-08-19 · reported 2026-08-19

Bancel described the significance of the personalized mRNA cancer treatment in the news release.